TY - JOUR
T1 - Spectrum of Results After Treatment of Rhinophyma With the Carbon Dioxide Laser
AU - el-AZHARY, ROKEA A.
AU - ROENIGK, RANDALL K.
AU - WANG, TOM D.
PY - 1991
Y1 - 1991
N2 - Between 1986 and 1989, 30 patients with rhinophyma were treated with the carbon dioxide (CO2) laser at our institution. The duration of disease ranged from 1 to 20 years, and the duration of follow-up ranged from 1 to 4 years. All the patients were men, and all had fair skin (predominantly type I skin); their mean age was 63 years. Patients with minor and moderate rhinophyma were treated with CO2 laser vaporization only, whereas patients with major rhinophyma were treated sequentially with CO2 laser excision and then vaporization. A spectrum of long-term results is presented. Although dilated pores developed in many patients, no re-treatment with the CO2 laser was necessary. In one patient each, leukoderma, unilateral alar lift, and mild hypertrophic scarring developed. In general, use of the CO2, laser is effective for precise decortication of rhinophyma in an office-outpatient setting.
AB - Between 1986 and 1989, 30 patients with rhinophyma were treated with the carbon dioxide (CO2) laser at our institution. The duration of disease ranged from 1 to 20 years, and the duration of follow-up ranged from 1 to 4 years. All the patients were men, and all had fair skin (predominantly type I skin); their mean age was 63 years. Patients with minor and moderate rhinophyma were treated with CO2 laser vaporization only, whereas patients with major rhinophyma were treated sequentially with CO2 laser excision and then vaporization. A spectrum of long-term results is presented. Although dilated pores developed in many patients, no re-treatment with the CO2 laser was necessary. In one patient each, leukoderma, unilateral alar lift, and mild hypertrophic scarring developed. In general, use of the CO2, laser is effective for precise decortication of rhinophyma in an office-outpatient setting.
UR - http://www.scopus.com/inward/record.url?scp=0025923726&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0025923726&partnerID=8YFLogxK
U2 - 10.1016/S0025-6196(12)61576-6
DO - 10.1016/S0025-6196(12)61576-6
M3 - Article
C2 - 1921499
AN - SCOPUS:0025923726
SN - 0025-6196
VL - 66
SP - 899
EP - 905
JO - Mayo Clinic Proceedings
JF - Mayo Clinic Proceedings
IS - 9
ER -